University of Birmingham

International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Diversity change during the rise of tetrapods and the impact of the ‘carboniferous rainforest collapse’ (2018) Dunne E, Close RA, Button DJ, Brocklehurst N, Cashmore DD, Lloyd GT, Butler RJ Journal article Physical and environmental drivers of Paleozoic tetrapod dispersal across Pangaea (2018) Brocklehurst N, Dunne E, Cashmore D, Frӧbisch J Journal article, Original article Translating fictional characters – Alice and the Queen from the Wonderland in English and Czech (2018) Čermáková A, Mahlberg M Authored book Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 Study (2018) Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, Kremer A, et al. Conference contribution Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polyps (2018) Iacucci M, Trovato C, Daperno M, Akinola O, Greenwald D, Gross SA, Hoffman A, et al. Journal article Data-driven re-referencing of intracranial EEG based on independent component analysis (ICA) (2018) Michelmann S, Treder MS, Griffiths B, Kerren C, Roux F, Wimber M, Rollings D, et al. Journal article Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg (2018) Kirchhof G, Lindner JF, Achenbach S, Berger K, Blankenberg S, Fangerau H, Gimpel H, et al. Journal article Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study (2018) Calabrese E, Kucharzik T, Maaser C, Maconi G, Strobel D, Wilson SR, Zorzi F, et al. Journal article Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution